An experimental approach may arm immune cells against many strains, eliminating annual guesswork
Resurgent outbreaks of infectious diseases are sickening thousands, and the causes are societal
Genetic construction project shifts focus to making virus-resistant human cells
The device can already detect antibodies for measles and rubella
Decision paves path to the U.S.'s first medication made from marijuana
Evolutionary studies indicate that the genetic changes enabling a cancer to develop arise shockingly early within the primary tumor. This discovery points to a promising new approach to therapy...
Pristine lab conditions may not provide the best model for human disease
Epigenetics may play a role
Two new studies support this correlation
Could scientists one day use blood and skin cells to replace sperm and eggs?
Computational models representing human heart cells show higher accuracy than animal models in predicting an adverse drug effect, such as dangerous arrhythmias
WHO’s lead detective says one in ten sold may be poor quality or fake
The White House says it will boost treatment and strengthen law enforcement
The history of Warfarin is a surprisingly bloody one. Find out how this anticoagulant drug went from cow-killer to life-saver in this Nature Video animation. This video was reproduced with permission and was first published on March 13, 2018...
The whipworm lives in the human gut, mooching microbes from its host to build its own microbiome. Christopher Intagliata reports.
Rumors about poisoned vaccines are making this bacterial infection hard to control
The explosion of health-related data could transform clinical trials and drug development. But only if we learn how to make sense of the data first.
A century after the “Great Influenza” struck infectious disease specialists still fear the emergence of viral diseases they will not be able to control, including influenza
A protein found in spit prevents bad bugs from binding to intestinal cells in the lab, pointing to a possible way to lower the chances of dysentery. Christopher Intagliata reports.
The 23andMe genetic offering “has a lot of caveats”